Lehrstuhl für Strahlentherapie

Low-dose-rate Prostate Brachytherapy: Characterization of Seeds Dynamics within the Prostate (2022) Karius A, Lotter M, Kreppner S, Lubgan D, Grigo J, Fietkau R, Strnad V, Bert C Conference contribution Reporting and Evaluation System for Incidents in the Radiation Therapy to increase Patient Safety, Treatment Quality and the Efficiency of Process Flows (2022) Kornek D, Lang-Welzenbach M, Beck A, Reinhardt A, Brandt T, Bert C Conference contribution Phase II Study: Accelerated Partial Breast Irradiation (APBI) on a Linear Accelerator (2022) Ott O, Schweizer C, Strnad V, Stillkrieg W, Lambrecht U, Fietkau R Conference contribution LDRT induces long-lasting Pain and Immunomodulating Effects in chronic degenerative and inflammatory Diseases - Results from the IMMO-LDRT01 Study (2022) Donaubauer AJ, Weissmann T, Fröhlich B, Becker I, Ott O, Fietkau R, Gaipl U, Frey B Conference contribution Magnetic Resonance thermometry images of hyperthermia treatments of sarcomas for prediction of therapy responses-need of data reprocessing and cleaning (2022) Khatun R, Hader M, Schmidt M, Bert C, Wadepohl M, Fietkau R, Ott J, et al. Conference contribution Development of Recurrence and Long-term Toxicity in Prostate Carcinoma after combined Radiotherapy with interstitial Brachytherapy Boost (2022) Schweizer C, Strnad V, Fietkau R Conference contribution Both Gender and Inflammatory Status play a Role in the low-dose Rontgen Therapy Effect on Synovial Fibroblasts (2022) Völlings A, Piltz M, Titova E, Wolff T, Weissmann T, Fietkau R, Frey B, et al. Conference contribution Integration of a Halcyon Accelerator with ARIA in a Mosaiq - Environment - Risk Analysis Procedure (2022) Shariff M, Lotter M, Lambrecht U, Bert C Conference contribution Hypofractionated Irradiation increases the Expression of the Immune Checkpoint Molecule HVEM on TS/A, 4T1-luc and E0771 Breast Carcinoma Cells (2022) Flohr AS, Fietkau R, Rückert M, Gaipl U Conference contribution The Effect of Hyperthermia and Radiotherapy Sequence on Cancer Cell Death and the Immune Phenotype of Breast Cancer Cells (2022) Sengedorj A, Hader M, Heger L, Frey B, Dudziak D, Fietkau R, Ott O, et al. Journal article